Oncolytics Biotech (Oncolytics Biotech) Other Operating Expense : $0.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Oncolytics Biotech Other Operating Expense?

Oncolytics Biotech's Other Operating Expense for the three months ended in Dec. 2023 was $0.08 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.23 Mil.

Oncolytics Biotech's quarterly Other Operating Expense increased from Jun. 2023 ($0.07 Mil) to Sep. 2023 ($0.08 Mil) and increased from Sep. 2023 ($0.08 Mil) to Dec. 2023 ($0.08 Mil).

Oncolytics Biotech's annual Other Operating Expense declined from Dec. 2021 ($0.35 Mil) to Dec. 2022 ($0.29 Mil) but then increased from Dec. 2022 ($0.29 Mil) to Dec. 2023 ($0.30 Mil).

Oncolytics Biotech Other Operating Expense Historical Data

The historical data trend for Oncolytics Biotech's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Other Operating Expense Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

7.26

0.35

0.29

0.30

Oncolytics Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															0.07	-	0.07	0.08	0.08

Oncolytics Biotech Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.23 Mil.

Oncolytics Biotech Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Oncolytics Biotech's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncolytics Biotech (Oncolytics Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (NAS:ONCY) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The primary focus is to advance programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies.